Position in MGTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$104,837
New position
Shares Held
12,106
first reported quarter
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF NOVA SCOTIA holds $148,137,503 across 17 Biotechnology names. MGTX ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
97,520 | $75,347,852 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
1,310,387 | $36,297,719 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,361 | $15,790,100 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
135,960 | $8,524,692 | |
| 5 | INCY |
Incyte Corp
|
27,500 | $2,588,300 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,798 | $2,580,124 | |
| 7 | INSM |
INSMED Inc
|
15,203 | $2,485,994 | |
| 8 | ANTX |
AN2 Therapeutics, Inc.
|
459,194 | $1,570,443 |
All Filings in MGTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $104,837 | 12,106 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||